Editorial Policy

This site publishes two kinds of material: provider listings, which are generated from a federal registry and governed by our methodology, and editorial content — the explanations of GLP-1 medications, specialty descriptions, and FAQ answers that appear alongside those listings. This page covers the second kind.

Standards

We describe, we do not prescribe. Editorial content on this site explains how care is typically organized — what an obesity medicine specialist does, what to ask a clinic before booking, how telehealth evaluation generally works. It never tells an individual reader what treatment to take, at what dose, or whether a medication is right for them. Those are decisions for a licensed provider who knows your history.

Claims are limited to what is well established. We write about GLP-1 receptor agonists at the level of settled clinical consensus and FDA labeling. We do not report on preliminary studies, off-label protocols, dosing strategies, or compounded-medication sourcing.

Uncertainty is stated, not smoothed over. Where cost, coverage, availability, or clinical suitability genuinely vary — and for GLP-1 care they vary enormously — we say so rather than offering a confident average that would mislead most readers.

No superlatives about providers. We do not describe any listed clinic as best, top-rated, leading, or recommended, and we do not publish rankings. We have not evaluated these practices and will not imply that we have.

Medical review

Clinical editorial content will be reviewed by a licensed provider before publication, and reviewed pages will carry the reviewer’s name, credential, and the date of review. That process is being established; the status below states where it stands today.

Status: medical review is being established. Until a named reviewer is in place, no page on this site carries a review byline, and clinical content is deliberately limited to descriptive, non-directive material of the kind above. We would rather publish a narrower set of claims than attach an unearned stamp of clinical authority to them.

Independence from advertising

This site is operated by Amerigo Health, LLC, which also runs TransformationHealth, the telehealth service advertised here. That is the only advertiser, and no clinic pays for placement. See About for the full disclosure.

The editorial consequence of that arrangement is a rule we hold ourselves to: editorial content is not written to make telehealth look like the better answer. Where in-person care is the more appropriate choice — complex medical history, a preference for hands-on evaluation and in-office labs, a desire to consolidate care with an existing physician — our content says so directly, including on the telehealth pages themselves.

Promotional material is always visually distinct from directory listings and editorial content, and is always labeled.

Corrections

If we publish something inaccurate, we fix it. Substantive corrections to editorial content are made in place and the page’s “last updated” date is changed. We do not silently rewrite material that a reader may have relied on.

To report an error in editorial content or in a provider listing, contact us.

What we will never do

• Publish content written to rank for a search query rather than to answer it
• Present advertising as editorial content
• Publish user-submitted reviews or ratings of the providers we list
• Make individualized medical claims or promise clinical outcomes
• Accept payment from any listed clinic in exchange for inclusion, position, or removal